Medical Staffing Limited 06750180 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is that of a temporary recruitment agency. Digita Accounts Production Advanced 6.30.9574.0 true true true true 06750180 2023-01-01 2023-12-31 06750180 2023-12-31 06750180 bus:Director7 2023-12-31 06750180 bus:OrdinaryShareClass1 2023-12-31 06750180 bus:Consolidated 2023-12-31 06750180 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 06750180 core:RetainedEarningsAccumulatedLosses 2023-12-31 06750180 core:ShareCapital 2023-12-31 06750180 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 06750180 core:WithinOneYear 2023-12-31 06750180 core:FurnitureFittingsToolsEquipment 2023-12-31 06750180 bus:FRS102 2023-01-01 2023-12-31 06750180 bus:Audited 2023-01-01 2023-12-31 06750180 bus:FullAccounts 2023-01-01 2023-12-31 06750180 bus:RegisteredOffice 2023-01-01 2023-12-31 06750180 bus:Director1 2023-01-01 2023-12-31 06750180 bus:Director2 2023-01-01 2023-12-31 06750180 bus:Director7 2023-01-01 2023-12-31 06750180 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 06750180 bus:Consolidated 2023-01-01 2023-12-31 06750180 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 06750180 bus:Agent1 2023-01-01 2023-12-31 06750180 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 06750180 core:ShareCapital 2023-01-01 2023-12-31 06750180 core:LandBuildingsUnderOperatingLeases 2023-01-01 2023-12-31 06750180 core:ComputerEquipment 2023-01-01 2023-12-31 06750180 core:FurnitureFittings 2023-01-01 2023-12-31 06750180 core:FurnitureFittingsToolsEquipment 2023-01-01 2023-12-31 06750180 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-01-01 2023-12-31 06750180 core:UKTax 2023-01-01 2023-12-31 06750180 countries:AllCountries 2023-01-01 2023-12-31 06750180 countries:EnglandWales 2023-01-01 2023-12-31 06750180 2022-12-31 06750180 core:RetainedEarningsAccumulatedLosses 2022-12-31 06750180 core:ShareCapital 2022-12-31 06750180 core:FurnitureFittingsToolsEquipment 2022-12-31 06750180 2022-01-01 2022-12-31 06750180 2022-12-31 06750180 bus:OrdinaryShareClass1 2022-12-31 06750180 core:AcceleratedTaxDepreciationDeferredTax 2022-12-31 06750180 core:RetainedEarningsAccumulatedLosses 2022-12-31 06750180 core:ShareCapital 2022-12-31 06750180 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 06750180 core:WithinOneYear 2022-12-31 06750180 core:FurnitureFittingsToolsEquipment 2022-12-31 06750180 core:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 06750180 core:ShareCapital 2022-01-01 2022-12-31 06750180 core:LandBuildingsUnderOperatingLeases 2022-01-01 2022-12-31 06750180 core:UKTax 2022-01-01 2022-12-31 06750180 2021-12-31 06750180 core:RetainedEarningsAccumulatedLosses 2021-12-31 06750180 core:ShareCapital 2021-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 06750180

Medical Staffing Limited

Annual Report and Financial Statements

for the Year Ended 31 December 2023

 

Medical Staffing Limited

Contents

Company Information

1

Directors' Report

2

Strategic Report

3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Profit and Loss Account

8

Balance Sheet

9

Statement of Changes in Equity

10

Notes to the Financial Statements

11 to 18

 

Medical Staffing Limited

Company Information

Directors

R B Sanders

J Stevenson

Registered office

Suite B
Floor 2
400 Capability Green
Luton
LU1 3LU

Bankers

HSBC Bank PLC
44-52 Lattimore Road
St Albans
Hertfordshire
AL1 3XL

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Medical Staffing Limited

Directors' Report for the Year Ended 31 December 2023

The directors present their report and the financial statements for the year ended 31 December 2023.

Directors of the company

The directors who held office during the year were as follows:

R B Sanders

J Stevenson

D M Weitzmann (resigned 28 February 2023)

Disclosure of information to the auditors

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Reappointment of auditors

Hazlewoods LLP have expressed their willingness to continue in office.

Approved by the Board on 29 August 2024 and signed on its behalf by:


R B Sanders
Director

 

Medical Staffing Limited

Strategic Report for the Year Ended 31 December 2023

The directors present their strategic report for the year ended 31 December 2023.

Principal activity

The principal activity of the company is that of a temporary recruitment agency.

Fair review of the business

The results for the year, which are set out in the profit and loss account, show turnover of £15,748,692 (2022 - £24,400,518) and an operating profit of £50,689 (2022 - £408,532). At 31 December 2023, the company had net assets of £200,176 (2022 - £458,955). The directors consider the performance for the year and the financial position at the year end to be satisfactory.

Principal risks and uncertainties

The management of the business and the execution of the strategy of the company are subject to a number of risks. The key business risks and uncertainties affecting the company are considered to relate to competition from both national and local providers of temporary recruitment.

Objectives and policies

The directors constantly monitor the company's trading results and revise projections as appropriate to ensure that the company can meet its future obligations as they fall due.

Financial instruments

Price risk, credit risk, liquidity risk and cash flow risk

In accordance with the Financial Reporting Council's 'Going Concern and Liquidity Risk: Guidance for Directors of UK Companies 2009', the directors of all companies are now required to provide disclosures regarding the adoption of the going concern basis of accounting.

The company has sufficient resources available and the directors have prepared forecasts for the next 12 months that indicate that this will continue to be the case and that these cash flows will be sufficient for the company to meet its financing commitments as they fall due. The directors therefore have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and have continued to adopt the going concern basis in preparing the financial statements.

Future developments

The external commercial environment is expected to remain competitive going forwards, however, the directors
remain confident that the company will continue to improve its current level of performance in the future and will
continue to trade as a going concern.

Approved by the Board on 29 August 2024 and signed on its behalf by:


R B Sanders
Director

 

Medical Staffing Limited

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report, Strategic Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards has been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Medical Staffing Limited

Independent Auditor's Report to the Members of Medical Staffing Limited

Opinion

We have audited the financial statements of Medical Staffing Limited (the 'company') for the year ended 31 December 2023, which comprise the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 December 2023 and of its loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Medical Staffing Limited

Independent Auditor's Report to the Members of Medical Staffing Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We considered the nature of the company’s industry and its control environment and reviewed the company’s documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management about their own identification and assessment of the risks of irregularities.

We obtained an understanding of the legal and regulatory framework that the company operates in and identified the key laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements, including the UK Companies Act and tax legislation, and, those that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty.

We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

 

Medical Staffing Limited

Independent Auditor's Report to the Members of Medical Staffing Limited

In common with all audits conducted in accordance with ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override of controls. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgements made in accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.

In addition to the above, our procedures to respond to the risks identified included the following:

reviewing financial statement disclosures by testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatements due to fraud;

enquiring of management concerning actual and potential litigation and claims and instances of non-compliance with laws and regulations; and

reading minutes of meetings of those charged with governance.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.





Martin Howard (Senior Statutory Auditor)
For and on behalf of Hazlewoods LLP, Statutory Auditor

Windsor House
Bayshill Road
Cheltenham
GL50 3AT

29 August 2024

 

Medical Staffing Limited

Profit and Loss Account for the Year Ended 31 December 2023

Note

2023
£

2022
£

Turnover

3

15,748,692

24,400,518

Cost of sales

 

(13,180,698)

(20,443,456)

Gross profit

 

2,567,994

3,957,062

Administrative expenses

 

(2,495,830)

(3,548,530)

Exceptional items

5

(21,475)

-

Operating profit

4

50,689

408,532

Other interest receivable and similar income

6

6

52

Interest payable and similar charges

7

(288,536)

(229,369)

(Loss)/profit before tax

 

(237,841)

179,215

Taxation

11

(20,938)

-

(Loss)/profit for the financial year

 

(258,779)

179,215

The above results were derived from continuing operations.

The company has no other comprehensive income for the year.

 

Medical Staffing Limited

(Registration number: 06750180)
Balance Sheet as at 31 December 2023

Note

2023
 £

2022
 £

Fixed assets

 

Tangible assets

12

1,426

17,109

Current assets

 

Debtors

13

5,187,258

5,716,238

Cash at bank and in hand

 

56,913

103,836

 

5,244,171

5,820,074

Creditors: Amounts falling due within one year

14

(5,044,878)

(5,376,391)

Net current assets

 

199,293

443,683

Total assets less current liabilities

 

200,719

460,792

Provisions for liabilities

11

(543)

(1,837)

Net assets

 

200,176

458,955

Capital and reserves

 

Called up share capital

17

2

2

Profit and loss account

200,174

458,953

Total equity

 

200,176

458,955

Approved and authorised by the Board on 29 August 2024 and signed on its behalf by:
 


R B Sanders
Director

 

Medical Staffing Limited

Statement of Changes in Equity for the Year Ended 31 December 2023

Share capital
£

Profit and loss account
£

Total
£

At 1 January 2023

2

458,953

458,955

Loss for the year

-

(258,779)

(258,779)

At 31 December 2023

2

200,174

200,176

Share capital
£

Profit and loss account
£

Total
£

At 1 January 2022

2

279,738

279,740

Profit for the year

-

179,215

179,215

At 31 December 2022

2

458,953

458,955

 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

 

1

General information

The company is incorporated and domiciled in England and Wales.

The address of its registered office is:
Suite B
Floor 2
400 Capability Green
Luton
LU1 3LU

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Summary of disclosure exemptions

The company has not presented a cash flow statement on the grounds that the company is a wholly owned subsidiary and a group cash flow statement is included in the financial statements of the ultimate parent company.

Name of parent of company

These financial statements are consolidated in the financial statements of Lucess Investco Limited.

The financial statements of Lucess Investco Limited may be obtained from Companies House.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

20% straight line

Computer equipment

33% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

 

3

Turnover

The total turnover of the company has been derived from its principal activity wholly undertaken in the United Kingdom.

 

4

Operating profit

Operating profit is arrived at after charging:

2023
 £

2022
 £

Depreciation expense

4,069

13,261

Operating lease expense - property

3,660

-

 

5

Exceptional items

2023
 £

2022
 £

Exceptional expenses

21,475

-

Exceptional items in the current year relate to non-recurring expenses for outsourcing administrative work.

 

6

Other interest receivable and similar income

2023
£

2022
£

Interest income on bank deposits

6

52

 

7

Interest payable and similar charges

2023
£

2022
£

Interest on bank overdrafts and borrowings

262,065

229,369

Interest expense on other finance liabilities

26,471

-

288,536

229,369

 

8

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2023
 £

2022
 £

Wages and salaries

736,151

1,049,507

Social security costs

57,364

94,888

Pension costs, defined contribution scheme

2,147

1,986

795,662

1,146,381

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2023
 No.

2022
 No.

Number of employees

13

20

 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

 

9

Directors' remuneration

No directors' remuneration for the year was charged in this company. The directors' remuneration has been incurred by a company under common control.

 

10

Auditors' remuneration

Auditors' remuneration has been borne by a fellow group undertaking.

 

11

Taxation

Tax charged/(credited) in the profit and loss account

2023
£

2022
£

Current taxation

UK corporation tax adjustment to prior periods

22,232

-

Deferred taxation

Arising from origination and reversal of timing differences

(1,294)

-

Tax expense in the income statement

20,938

-

The tax on profit before tax for the year is lower than the standard rate of corporation tax in the UK (2022 - lower than the standard rate of corporation tax in the UK) of 23.5% (2022 - 19%).

The differences are reconciled below:

2023
 £

2022
 £

(Loss)/profit before tax

(237,841)

179,215

Corporation tax at standard rate

(55,893)

34,051

Effect of expense not deductible in determining taxable profit

6,477

104

Increase (decrease) in UK and foreign current tax from adjustment for prior periods

22,232

-

Tax (decrease) from effect of capital allowances and depreciation

3,448

1,884

Tax increase (decrease) from other short-term timing differences

(1,294)

-

Tax increase (decrease) arising from group relief

45,968

(36,039)

Total tax charge

20,938

-

 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

Deferred tax

Deferred tax assets and liabilities

2023

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

543

2022

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

1,837

 

12

Tangible assets

Furniture, fittings and equipment
 £

Cost

At 1 January 2023

56,322

Disposals

(52,347)

At 31 December 2023

3,975

Depreciation

At 1 January 2023

39,213

Charge for the year

4,069

Eliminated on disposal

(40,733)

At 31 December 2023

2,549

Carrying amount

At 31 December 2023

1,426

At 31 December 2022

17,109

 

13

Debtors

2023
 £

2022
 £

Trade debtors

1,415,843

2,215,662

Amounts owed by group undertakings

3,699,242

3,036,366

Other debtors

59,489

435,659

Prepayments

12,684

6,319

Corporation tax asset

-

22,232

 

5,187,258

5,716,238

 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

 

14

Creditors

2023
 £

2022
 £

Due within one year

Trade creditors

124,785

83,950

Amounts due to group undertakings

2,980,108

2,076,486

Social security and other taxes

541,694

764,143

Outstanding defined contribution pension costs

822

1,491

Other creditors

1,312,520

2,034,757

Accrued expenses

84,949

415,564

5,044,878

5,376,391

The amounts owed under confidential invoice discounting arrangements of £1,192,565 (2022 - £2,034,757), included within other creditors, are secured by a fixed and floating charge against the Companies' property and undertakings.

 

15

Pension and other schemes

Defined contribution pension scheme

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £2,147 (2022 - £1,986).

Contributions totalling £822 (2022 - £1,491) were payable to the scheme at the end of the year and are included in creditors.

 

16

Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

2023
£

2022
£

Not later than one year

-

7,200

 

17

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary shares of £1 each

2

2

2

2

         
 

Medical Staffing Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

 

18

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be the directors of the company and key management personnel compensation is disclosed in note 9 to the financial statements.

 

19

Parent and ultimate parent undertaking

The company's immediate parent is Celsus Group Limited, incorporated in England and Wales.

 The ultimate parent is Lucess InvestCo Limited, incorporated in England and Wales .

There is considered to be no single controlling party of Lucess InvestCo Limited.